Results 1 to 10 of about 581,668 (293)

Novel Recurrence Relations for Volumes and Surfaces of n-Balls, Regular n-Simplices, and n-Orthoplices in Real Dimensions

open access: yesMathematics, 2022
This study examines n-balls, n-simplices, and n-orthoplices in real dimensions using novel recurrence relations that remove the indefiniteness present in known formulas.
Szymon Łukaszyk
doaj   +1 more source

A Deep Learning Model for Automatic Citation Document Recommendation in Non-Obviousness Judgment: Using BERT-for-patents and Contrastive Learning

open access: yesJournal of Intellectual Property
Patent laws in various countries stipulate that inventions identical to or easily derivable from prior art lack novelty and non-obviousness, rendering them ineligible for registration. To assess these criteria, prior art searches are conducted.
Dongkun Yoo, Jiheon Han
doaj   +1 more source

Does the political will exist to bring quality-assured and affordable drugs to low- and middle-income countries?

open access: yesGlobal Health Action, 2019
Background: Increased coverage with antiretroviral therapy for people living with HIV in low- and middle-income countries has increased their life expectancy associated with non-HIV comorbidities and the need for quality-assured and affordable non ...
Eduard J. Beck   +11 more
doaj   +1 more source

Exploring Family Relations between International Patent Applications

open access: yesBiomath, 2012
In the international system for granting patents for inventions, first patent filings can be followed by subsequent filings at other patent offices within one year. Each such group of related filings constitutes a patent family. Tests are developed as to
Peter Hingley
doaj   +1 more source

The kinetic relativity theory – hiding in plain sight

open access: yesOpen Physics
A question in physics is whether Special Relativity (SR) is the only theory that explains relativistic behavior. SR measures time dilation by a relative velocity between two frames.
Loen Mark V.
doaj   +1 more source

mRNA vaccines and therapeutics beyond COVID-19: A review of the global clinical development landscape, low- and middle-income countries involvement and relevance to their contexts

open access: yesHuman Vaccines & Immunotherapeutics
mRNA vaccines demonstrated transformative potential during the COVID-19 pandemic, yet global access to mRNA research, development, and manufacturing capacity remains unequal.
Monica Moschioni   +8 more
doaj   +1 more source

Essential Oils as Feed Additives—Future Perspectives

open access: yesMolecules, 2018
The inconsistency of phytogenic feed additives’ (PFA) effects on the livestock industry poses a risk for their use as a replacement for antibiotic growth promoters.
Zora Dajić Stevanović   +4 more
doaj   +1 more source

TERM EXTENSION OF DRUG PATENTS IN RUSSIA (REVIEW OF LEGISLATION AMENDMENTS)

open access: yesРазработка и регистрация лекарственных средств, 2019
The article describes the procedure of patent term extension to be granted on inventions relating to drugs and of granting a supplementary patent in view of recent amendments introduced in the Civil Code of the Russian Federation.
K. V. Osipov
doaj  

Effects of a Multicomponent Mycotoxin Detoxifying Agent on Health and Performance of Weaned Pigs Under Combined Dietary Exposure to Deoxynivalenol (DON) and Zearalenone (ZEN)

open access: yesToxins
The aim of the present study was to evaluate the efficacy of a multicomponent mycotoxin detoxifying agent (MMDA, MYCORAID, Patent Co, Mišićevo, Serbia) in weaned pigs receiving contaminated feed with deoxynivalenol (DON) and zearalenone (ZEN).
Jog Raj   +5 more
doaj   +1 more source

Multi-Mycotoxin Contamination in Serbian Maize During 2021–2023: Climatic Influences and Implications for Food and Feed Safety

open access: yesToxins
Mycotoxin contamination in maize poses significant food and feed safety risks, particularly in regions with variable climatic conditions like Serbia. This study investigated the occurrence of regulated mycotoxins in maize harvested across the Republic of
Felipe Penagos-Tabares   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy